Optimizing medical treatment of abdominal aortic aneurysm: interest of vascular centers - Université de Lille Accéder directement au contenu
Article Dans Une Revue La Presse medicale Année : 2018

Optimizing medical treatment of abdominal aortic aneurysm: interest of vascular centers

Résumé

Diagnosis of abdominal aortic aneurysm (AAA) at preoperative stage is increasingly frequent. It carries both a local risk of rupture and an increased global cardiovascular risk. Patients with AAA have indeed a 20 times higher risk of dying from myocardial infarction or stroke than from a ruptured aneurysm. Cardiovascular risk factors control is therefore essential, particularly smoking cessation. Treatment in cardiovascular prevention is also warranted. Seeking for atheromatous sites is needed as they determine prognosis. Evidence of the benefit of medical treatment to slow AAA growth is still lacking. In practice, it is recommended to prescribe statins and angiotensin converting enzyme inhibitor to prevent cardiovascular events. These preventive measures are as well necessary to improve postoperative prognosis and must be continued after surgical repair. A vascular medical and surgical cooperation is primordial to enhance comprehensive management of patients with AAA.
Fichier non déposé

Dates et versions

hal-04491588 , version 1 (06-03-2024)

Identifiants

Citer

Anne-Laure Madika, Claire Mounier-Vehier, Richard Oussama Azzaoui. Optimizing medical treatment of abdominal aortic aneurysm: interest of vascular centers. La Presse medicale, 2018, La Presse medicale, 47 (2), pp.161-166. ⟨10.1016/j.lpm.2018.01.019⟩. ⟨hal-04491588⟩

Collections

UNIV-LILLE
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More